(Q42937943)

11 November 2017

Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation (English)

1 reference

11 November 2017

0 references

1 reference

Shigeo Koido

1

1 reference

11 November 2017

Sadamu Homma

2

1 reference

11 November 2017

Masato Okamoto

3

1 reference

11 November 2017

Yoshihisa Namiki

4

1 reference

11 November 2017

Shin Kan

5

1 reference

11 November 2017

Kazuki Takakura

6

1 reference

11 November 2017

Mikio Kajihara

7

1 reference

11 November 2017

Kan Uchiyama

8

1 reference

11 November 2017

Eiich Hara

9

1 reference

11 November 2017

Toshifumi Ohkusa

10

1 reference

11 November 2017

Jianlin Gong

11

1 reference

11 November 2017

Hisao Tajiri

12

1 reference

11 November 2017

1 July 2013

1 reference

11 November 2017

1 reference

11 November 2017

2

1 reference

11 November 2017

8

1 reference

11 November 2017

e25375

1 reference

Fusions between dendritic cells and whole tumor cells as anticancer vaccines

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805650

Augmentation of antitumor immunity by fusions of ethanol-treated tumor cells and dendritic cells stimulated via dual TLRs through TGF-β1 blockade and IL-12p70 production.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805650

Combined TLR2/4-activated dendritic/tumor cell fusions induce augmented cytotoxic T lymphocytes

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805650

The blockade of immune checkpoints in cancer immunotherapy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805650

Gene silencing of TGF-β1 enhances antitumor immunity induced with a dendritic cell vaccine by reducing tumor-associated regulatory T cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805650

Cancer vaccine by fusions of dendritic and cancer cells

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805650

Systemic inhibition of transforming growth factor-beta in glioma-bearing mice improves the therapeutic efficacy of glioma-associated antigen peptide vaccines

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805650

Synergistic enhancement of CD8+ T cell-mediated tumor vaccine efficacy by an anti-transforming growth factor-beta monoclonal antibody

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805650

Expression of a soluble TGF-beta receptor by tumor cells enhances dendritic cell/tumor fusion vaccine efficacy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3805650

Induction of antitumor activity by immunization with fusions of dendritic and carcinoma cells

27 May 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24167764

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/ONCI.25375

1 reference

11 November 2017

1 reference

11 November 2017

PubMed publication ID

24167764

1 reference